Miltown-400 en es it fr

Miltown-400 Brand names, Miltown-400 Analogs

Miltown-400 Brand Names Mixture

  • No information avaliable

Miltown-400 Chemical_Formula


Miltown-400 RX_link

No information avaliable

Miltown-400 fda sheet

Miltown-400 msds (material safety sheet)

Miltown-400 Synthesis Reference

No information avaliable

Miltown-400 Molecular Weight

309.469 g/mol

Miltown-400 Melting Point

< 25 oC

Miltown-400 H2O Solubility

Soluble as HCl salt

Miltown-400 State


Miltown-400 LogP


Miltown-400 Dosage Forms

Tablets (oral, 1 mg)

Miltown-400 Indication

Used for the symptomatic treatment of parkinsonism.

Miltown-400 Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Miltown-400 Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Miltown-400 side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Miltown-400 Patient Information

Miltown-400 Organisms Affected

Humans and other mammals